CARsgen Therapeutics Holdings (CARsgen Therapeutics Holdings) Net Issuance of Debt : $-0.68 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is CARsgen Therapeutics Holdings Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. CARsgen Therapeutics Holdings's net issuance of debt for the six months ended in Dec. 2023 was $-0.34 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.68 Mil.

CARsgen Therapeutics Holdings Net Issuance of Debt Historical Data

The historical data trend for CARsgen Therapeutics Holdings's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings Net Issuance of Debt Chart

CARsgen Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

-28.75

1.87

22.98

-31.46

-0.68

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Issuance of Debt	Get a 7-Day Free Trial				7.77	0.23	-31.68	-0.33	-0.34

CARsgen Therapeutics Holdings Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.68 Mil.

CARsgen Therapeutics Holdings Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings (CARsgen Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (OTCPK:CRTHF) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

02171:Hong Kong

Address

No. 388 Yindu Road, Building 12, CMC Preparation Center, Xuhui District, Shanghai, CHN

Website

https://www.carsgen.com

CARsgen Therapeutics Holdings Ltd is a global clinical-stage biopharmaceutical company discovering, researching and developing cell therapies in the People's Republic of China and the United States of America.